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Abstract
Background
The control and elimination of Plasmodium vivax will require a better understanding of its
transmission dynamics, through the application of genotyping and population genetics anal-
yses. This paper describes VivaxGEN (http://vivaxgen.menzies.edu.au), a web-based plat-
form that has been developed to support P. vivax short tandem repeat data sharing and
comparative analyses.
Results
The VivaxGEN platform provides a repository for raw data generated by capillary electro-
phoresis (FSA files), with fragment analysis and standardized allele calling tools. The query
system of the platform enables users to filter, select and differentiate samples and alleles
based on their specified criteria. Key population genetic analyses are supported including
measures of population differentiation (FST), expected heterozygosity (HE), linkage disequi-
librium (IAS), neighbor-joining analysis and Principal Coordinate Analysis. Datasets can also
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be formatted and exported for application in commonly used population genetic software
including GENEPOP, Arlequin and STRUCTURE. To date, data from 10 countries, includ-
ing 5 publicly available data sets have been shared with VivaxGEN.
Conclusions
VivaxGEN is well placed to facilitate regional overviews of P. vivax transmission dynamics
in different endemic settings and capable to be adapted for similar genetic studies of P. fal-
ciparum and other organisms.
Author summary
The Plasmodium vivax malaria parasite inflicts significant morbidity in endemic popula-
tions across the globe, but has been overshadowed by the more fatal P. falciparum parasite.
In malaria-endemic regions outside of Africa, the declining prevalence of P. falciparum is
coupled with a proportionate rise in P. vivax, reflecting the greater refractoriness of P. vivax
to transmission interventions. This worrying trend emphasizes the need for a better under-
standing of the patterns of P. vivax transmission and spread within and across borders.
Genotyping parasite population samples at short tandem repeat (STR) markers such as
microsatellites informs on diversity, population structure and underlying transmission pat-
terns. We have established vivaxGEN, an online platform providing a repository for P.
vivax STR genotyping data, and tools for standard population genetic analyses. The plat-
form currently holds publicly available data from 5 vivax-endemic countries that can be
browsed on the website (http://vivaxgen.menzies.edu.au). VivaxGEN will support research-
ers to conduct local STR-based P. vivax studies with greater autonomy and foster collabora-
tive studies enabling regional overviews of P. vivax diversity in different endemic settings
and across borders. The system can be adapted for STR-based analyses in other microor-
ganisms and the open access source code is provided to facilitate these developments.
Introduction
In the Asia-Pacific region, Plasmodium vivax is responsible for between 20 and 280 million
malaria cases per year, inflicting a significant burden of morbidity and mortality. Over the last
decade, the prevalence of P. falciparum has declined in many endemic countries as a result of
intensified malaria control interventions, but outside Africa this has been associated with a rise
in the proportion of P. vivax cases, reflecting the limited efficacy of interventions against this
species [1]. This trend emphasizes the need for innovative new strategies to reduce P. vivax
transmission. A critical weakness of conventional malaria surveillance is the lack of informa-
tion on the genetic dynamics of the parasite population—an important reflection of underlying
transmission potential. Previous studies have demonstrated the utility of genotyping parasite
population samples at highly polymorphic short tandem repeat (STR) markers such as micro-
satellites to inform on P. vivax diversity, population structure and underlying transmission
patterns [2–19]. These simple molecular approaches complement the more traditional mea-
sures of transmission intensity as well as providing a surrogate marker for transmission inten-
sity, informing on outbreak dynamics, reservoirs of infection, and the spread of infection
spread within and across borders [20,21].
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However, individual projects have limited potential to address regional questions. The chal-
lenges of imported and border malaria associated with highly mobile human populations
emphasizes the need for a framework to support integrated, multinational comparative analyses.
Effective comparison between studies and sites has been confounded by heterogeneity of meth-
odologies such as the number and location of markers used, size standards, allele calling/bin-
ning, and specifications for calling minor alleles reflecting minor clones in polyclonal infections
[22]. To address some of these challenges, the Vivax Working Group (VxWG) of the Asia
Pacific Malaria Elimination Network (APMEN) has worked with research partners in 15 Asia
Pacific countries to develop a consensus panel of STR markers (MS1, MS5, MS8, MS10, MS12,
MS16, MS20, pv3.27 and msp1F3) and genotyping methods [23]. The web-based VivaxGEN
platform was developed to facilitate standardized allele calling, data analysis and sharing across
P. vivax studies using consensus STR marker sets such as the APMEN panel. The VivaxGEN
platform provides a repository for FSA files (the primary data files containing the raw fragment
analysis data generated during capillary electrophoresis runs). To date, no such repository exists
for P. vivax STR data. The capacity to derive allelic data directly from the FSA files ensures high
accuracy and standardization in allele-calling between different sample batches produced at dif-
ferent time points and/or on different machines from possibly different studies. This feature
also supports flexibility in defining allele-calling thresholds, enabling user-defined settings that
may be applied to one or more sample batches. The VivaxGEN platform also provides tools for
standard population genetic analyses that can be applied to multiple sample batches to evaluate
local and regional trends in the prevalence of polyclonal infections, population diversity, struc-
ture and differentiation both spatially and temporally. Data export tools are available to allow
users to conduct more bespoke analyses not provided within the platform framework.
Methods
Ethics statement
All genotyping data described in the manuscript has been published [4,9,12,14,34]. As described
in the original publications, all samples were collected with written informed consent from the
patient, parent or legal guardian (individuals< 18 years of age). Approval was provided by the
Institutional Review Board of Jiangsu Institute of Parasitic Diseases (IRB00004221), Wuxi, China;
the Research Ethics Board of Health, Ministry of Health Bhutan (REBH 2012/031); the Korea
Centers for Disease Control and Prevention Institutional Review Board, Republic of Korea (Pro-
tocol No. 2011-02CON-14-P); the Eijkman Institute Research Ethics Commission, Indonesia
(EIREC 45/2011); the Ethics Review Board of Addis Ababa University College of Natural Sci-
ences, Ethiopia (RERC/002/05/2013); the Ethics Review Board of Armauer Hansen Research
Institute, Addis Ababa, Ethiopia (AHRI-ALERT P011/10); the National Research Ethics Review
Committee of Ethiopia (Ref.no. 3.10/580/06); and the Human Research Ethics Committee of the
Northern Territory Department of Health and Menzies School of Health Research, Darwin, Aus-
tralia (HREC 2012–1871, HREC-2012-1895 and HREC-13-1942).
System architecture and implementation
The VivaxGEN platform was developed as a multi-tier web application system, utilizing Post-
greSQL as its backend Relational Database Management System (RDBMS) and leveraging on
several common external tools for genotype data analysis. PostgreSQL was chosen as the
RDBMS as it provided ACID operations and complex SQL query optimization in an open-
source package. The backend is programmed in Python, while the web interface uses Java-
Script and jQuery library for interactivity. YAML was chosen as the format for platform con-
figuration and data exchange/interoperability. Sample and assay data uploading process can be
VivaxGEN: Plasmodium vivax genotyping analysis platform
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performed using either batch processing with tab or comma-delimited files in conjunction
with a zip file containing raw FSA files, or interactively using sample and assay editing inter-
face. Detailed instructions on data upload, and an accompanying tutorial dataset can be found
in Tutorial 1 (Uploading your metadata and FSA files) provided on the VivaxGEN website and
in S1 File.
Integrated fragment analysis tools
VivaxGEN provides a framework to store and process raw FSA files with standardized allele
calling tools. This framework reduces the heterogeneity that may be introduced from different
fragment analysis methods. A Python based library called FATOOLS, which can also be used
as a stand-alone command line utility, was developed to provide the raw FSA processing capa-
bilities in VivaxGEN. This library utilizes numpy (www.numpy.org) and scipy (https://www.
scipy.org) scientific libraries for its numerical processing. The library provides methods for
base normalization of traces, peak scanning and classification, standard size determination,
peak calling and allele annotation, as well as FSA assay quality controls. A detailed guide on
the FSA fragment analysis process in VivaxGEN can be found in the Guide on Fragment Anal-
ysis manual provided on the website and in S2 File. Briefly, base normalization is undertaken
using a top-hat morphological transform algorithm implemented in scipy. A simple peak find-
ing algorithm and a CWT-based peak scanning algorithm implemented in scipy are also
included in the library [24]. A combination of greedy algorithm and dynamic programming is
employed for standard size alignment and size determination. Results of each step of the FSA
and fragment analysis processing are stored in the system for aiding manual inspection and
assay verification. The source code for FATOOLS is available for stand-alone usage and further
development (http://github.com/trmznt/fatools). To aid the manual inspection of traces, a
trace viewer is included in the web interface, as shown in Fig 1. Detailed instructions on the
manual data editing tools can be found in Tutorial 2 (Inspecting FSA files and data cleaning)
provided on the VivaxGEN website and in S1 File. The trace viewer is coded in JavaScript and
enables users to identify and edit incorrectly annotated alleles.
Tools for allele and sample filtering
The form-based web interface also provides a number of allele and sample filtering options.
Details on the allele and sample filtering tools can be found in Tutorial 3 (Data analysis) pro-
vided on the VivaxGEN website and in S1 File. Alleles can be filtered according to marker
name (Marker), marker failure rate in the given sample set (Marker quality threshold), abso-
lute minimum relative fluorescence unit (RFU) (Allele absolute threshold) and relative RFU of
minor peaks compared to the highest intensity peak (Allele relative threshold). Suspected stut-
ter peaks can also be filtered according to a user-defined stutter range in base pairs (Stutter
range) and ratio (Stutter ratio) based on the RFU relative to the highest intensity peak in the
given range. Samples can also be filtered according to genotyping success rate across the given
marker set (Sample quality threshold), to exclude polyclonal infections or multi-locus geno-
types that are presented more than once in the given sample set (Sample filtering), or by pas-
sive versus active case detection (Detection differentiation).
Sample query system
Sample querying and grouping can be performed using a query syntax modeled on the NCBI
Entrez system with some modification. Detailed instructions on how to perform data analysis
using custom queries is provided in Tutorial 4 (Data analysis with custom query) provided on
the VivaxGEN website and in S1 File. Boolean operations can be applied to classify sample
VivaxGEN: Plasmodium vivax genotyping analysis platform
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groups based on spatial (by country level or by 1st, 2nd, 3rd or 4th administrative division level)
or temporal (by year or quartile of sample collection) definitions. The query from the form-
based web interface is converted into a YAML-based query internally, which can then be run
in the database. An interface that accepts YAML-based query is also provided, enabling the
user to apply bespoke sample grouping operations not supported by the form-based web inter-
face. Instructions on how to perform data analysis in VivaxGEN using YAML queries is pro-
vided in Tutorial 5 (Data analysis with YAML query) provided on the website and in S1 File.
Population genetic tools
A suite of population genetic measures and associated statistical tests that are commonly used
in STR-based P. vivax studies to gauge underlying patterns of transmission intensity, stability
and boundaries, including rates of polyclonality, population diversity, genetic relatedness, pop-
ulation structure and out-crossing/inbreeding rates, can be applied to the genotyping data
from one or more sample batches. Population genetic measures currently supported within
VivaxGEN include (i) expected heterozygosity (HE), an index of population-level diversity, (ii)
individual infection and population average measures of the Multiplicity of Infection (MOI), a
measure of the genetic complexity within infections, (iii) proportion of polyclonal infections,
Fig 1. Screenshot from the VivaxGEN platform illustrating the trace viewer features for visual inspection of allele peaks and manual
editing of allele annotations. The top panel of the screenshot presents a trace image highlighting examples of a short artefact peak from PET-
labelled primer-dimer (A), authentic alleles for each of PET, VIC and 6-FAM-labelled amplicons (B), a stutter peak from the 6-FAM-labelled
amplicon (C), and peaks for the LIZ600 size standard (D). The bottom panel of the figure presents the detailed annotation provided for each
peak detected by the fragment analysis scan with examples for the VIC-labelled (msp1F3) peaks. The manual edit options (E) whereby the user
can change peak annotation details are highlighted.
https://doi.org/10.1371/journal.pntd.0005465.g001
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and (iv) Principal Coordinate Analysis (PCoA) with plots illustrating the population structure
and genetic relatedness between infections based on a genetic distance matrix. External soft-
ware employed by the platform include (i) LIAN for measuring linkage disequilibrium (LD)
using the index of association (IAS) [25] as a gauge of out-crossing/inbreeding rates, (ii) Arle-
quin for measures of genetic differentiation between populations using the fixation index (FST)
[26], (iii) the APE (Analysis of Phylogenetics and Evolution) package in R for building neigh-
bor-joining trees for assessment of genetic relatedness between infections [27], (iv) the Facto-
MineR package in R for generating Multiple Correspondence Analysis (MCA) plots to assess
population structure and genetic relatedness based on the nominal categorical data [28], and
(v) the DEMEtics package in R for calculating the genetic differentiation index D [29,30]. A
standardized measure of genetic differentiation, F’ST, adjusted for marker diversity to support
greater comparability between studies using different marker sets is calculated internally in
VivaxGEN using the output from Arlequin and following the method described by Hedrick
[31]. Further details on the population genetic tools can be found in the Guide on Data Analy-
sis manual provided on the VivaxGEN website and in S2 File.
File format conversion module
The VivaxGEN platform has tools for exporting genotype data in several formats supported by
other commonly used population genetics softwares including LIAN [25], Arlequin [26], Gene-
pop [32] and STRUCTURE [33]. Tab-delimited formats suitable for R’s data frame or Python’s
pandas data frame are also provided.
Data access policy
VivaxGEN users may choose to keep their data private, accessible to all or only specified
researchers or they may allow their data to be open access. The repository currently holds data
obtained from published studies on P. vivax samples from China [12], Ethiopia [4], Indonesia
[14], South Korea [9] and Bhutan [34]. Private accounts have been generated for users with
data sets on P. vivax samples from Iran, Malaysia, Myanmar, and Vanuatu.
Availability
The platform can be accessed at http://vivaxgen.menzies.edu.au. The source code for the plat-
form, licensed under GNU GPL version 3, can be obtained from https://github.com/trmznt/
plasmogen.
Results and discussion
The VivaxGEN platform was developed as a framework to support standardized allele calling
and greater ease of data sharing for comparative analyses between different STR-based studies in
P. vivax. Relative to Single Nucleotide Polymorphisms (SNPs), where a maximum of 4 alleles
arising from the 4 different nucleotides are possible at a given position, STRs may exhibit dozens
of alleles, measured as different repeat lengths. Although STRs offer high discriminatory poten-
tial between independent infections, comparison of STR alleles (fragment size variants) between
different sample batches produced at different time points and/or in different laboratories is con-
siderably more challenging than comparison of the discrete allele forms generated from the anal-
ysis of SNPs. Despite the application of a size standard, replicates of the same sample may exhibit
slight variation (usually less than 1 bp difference) in fragment size. In order to address this varia-
tion, alleles can be assigned to bins encompassing a range of fragment sizes usually reflecting the
size of the repeat unit. However, whilst one researcher might assign fragment sizes of 254.4 bp
VivaxGEN: Plasmodium vivax genotyping analysis platform
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and 255.7 bp to two different allele bins such as “254” and “256” respectively, another researcher
might assign both alleles to bin “255”, and yet another might assign these fragment sizes to allele
bin “256”, creating artificial differentiation between datasets. As illustrated in Fig 2, the Vivax-
GEN platform provides a common interface for fragment size allele calling using the raw FSA
files and applying a standardized binning system, which facilitates comparability between differ-
ent datasets. By virtue of this feature, using the VivaxGEN platform, it was possible to identify a
distinct, population-specific allele profile at the MS20 locus in South Korea versus Bhutan, Ethio-
pia and Indonesia (Fig 3). The distinct MS20 allele profile observed in South Korea is postulated
to reflect a single major reservoir of P. vivax infections, most likely from North Korea [9]. Future
data entries to VivaxGEN on MS20 genotypes from other vivax-endemic regions are likely to
provide further important insights on this phenomenon and other transmission patterns.
One of the greatest challenges in genotyping Plasmodium samples (and other microorgan-
isms) is the identification and characterization of polyclonal infections [22]. Owing to artefacts
such as background noise, stutter peaks, and overlapping peaks (also known as pull-up peaks
Fig 2. Partial allele summary plot illustrating allele binning. The figure provides a zoomed in view of an allele
summary plot presenting MSP1F3 alleles from an Indonesian sample batch (blue allele peaks) and an Ethiopian
sample batch (green allele peaks), which were produced by different institutes on different machines. The black
allele peaks at the base of the plot are a composite of both the Indonesian and Ethiopian alleles. The allele
lengths in the bin defined as allele “256” (i.e. approximating 256 bp) were slightly shifted between Indonesia (A)
and Ethiopia (B), highlighting the potential for the same alleles to be assigned to different bins in Indonesia
(“255”) versus Ethiopia (“256”). The standardized binning within the VivaxGEN platform ensured that the ~255 bp
alleles in Indonesia and the ~256 bp alleles in Ethiopia were assigned to the same allele bin defined as “256”.
https://doi.org/10.1371/journal.pntd.0005465.g002
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or bleed) in multiplex reactions where amplicons are labelled with different fluoresceins. Some
of these artefacts may not be automatically detected and excluded from the peak binning dur-
ing the fragment scanning process. To address this challenge, the VivaxGEN platform provides
utilities enabling visual inspection of individual electropherogram traces and editing of allele
annotations. The platform also enables user-defined relative minimum RFU thresholds for
calling minor alleles: an approach that is commonly applied in STR-based Plasmodium studies
to reduce the prevalence of artefact peaks, and enhance comparability in the sensitivity to
detect minor peaks in samples of differing quality such as DNA derived from dried blood
spots versus blood tubes [35]. Different studies may however apply different thresholds. A ben-
efit of the integrated database and analytical framework in VivaxGEN is that population
genetic measures such as the average MOI or proportion of polyclonal infections can be com-
pared between different sample batches at the same user-defined threshold–and indeed multi-
ple different thresholds can be explored.
Capitalizing on the feature to incorporate samples from multiple studies (batches) within
an analytical procedure, we used the platform to compare multi-locus genotypes (MLGs)
between different published datasets stored in the database. As illustrated in Fig 4A, Multiple
Correspondence Analysis (MCA) demonstrated clear distinction of the MLGs at the 9
APMEN standard markers between Ethiopia, Indonesia and South Korea, whilst the Bhuta-
nese isolates displayed a broad range of MLGs with overlap in both Ethiopia and Indonesia. It
is widely acknowledged that different STR markers have different strengths in their ability to
detect polyclonal infections and/or to define population structure [36]. Amongst the APMEN
panel, 5 markers (MS1, MS5, MS10, MS12 and MS20) have been defined as “stable”, with opti-
mal utility for analysis of population differentiation [36]. Therefore, the effect of repeating the
analysis using the 5 stable markers was assessed (Fig 4B). A similar pattern was observed to the
full marker panel, adding assurance that the clustering patterns had not been affected by the
high diversity markers.
The integrated data repository, allele calling and data analysis tools in VivaxGEN promote
exploratory and semi-interactive analysis in a common web interface. Compared to other pop-
ular softwares for processing microsatellite data, VivaxGEN is unique in providing both the
capability to process and store raw electropherogram data (FSA files) and to perform statistical
and population genetic analysis commonly applied in studies of Plasmodium (Table 1). A data
export utility enables population genetic analysis outputs for a given parameter set to be down-
loaded from VivaxGEN to facilitate data reporting. These features greatly simplify data pro-
cessing and exploration, and should enable malaria researchers who are new to the field of
population genetics to conduct robust data analysis with greater autonomy. The integrated
Fig 3. Allele summary plot example for the MS20 locus in samples from different countries. The allele summary plot demonstrates
the distinct, population-specific allele profile at the MS20 locus in locally acquired infections from South Korea (purple) versus imported
infections from Brazil (green) and Cambodia (orange), and infections from studies conducted in Indonesia (blue), Ethiopia (brown) and
Bhutan (red). The plot uses data from VivaxGEN version 1.0.
https://doi.org/10.1371/journal.pntd.0005465.g003
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data repository should also foster collaborations between different research institutions and
allow analyses on regional trends as well as population differences between countries. The
Fig 4. MCA plots using 9 APMEN markers (panel A) and 5 APMEN markers (panel B) between Bhutan, Ethiopia,
Indonesia and South Korea samples. The plot uses data from VivaxGEN version 1.0.
https://doi.org/10.1371/journal.pntd.0005465.g004
VivaxGEN: Plasmodium vivax genotyping analysis platform
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outcomes will inform national malaria control and elimination programs on malaria transmis-
sion dynamics, may help distinguish local from imported parasite populations and facilitate
malaria surveillance.
Conclusions
The VivaxGEN platform is well placed to facilitate regional overviews of P. vivax population
genetic patterns in different endemic settings, informing on the underlying transmission
dynamics of this highly adaptive parasite. The system is amenable to being adapted for STR-
based analyses in P. falciparum and other microorganisms or other forms of genetic data such
as SNP-based genotypes. The open access source code is provided to facilitate developments
for such applications.
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